Previous 10 | Next 10 |
2024-06-03 18:09:10 ET Read the full article on Seeking Alpha For further details see: J&J, Legend release promising results on Carvykti in earlier treatment line
First analysis of CARTITUDE-2 Cohort D study investigating CARVYKTI ® in multiple myeloma with suboptimal response after front-line ASCT featured in an oral presentation at the 2024 ASCO Annual Meeting show deep and durable responses with one-time infusion of CARVYKTI ® ...
2024-05-31 07:30:07 ET Citigroup analyst issues BUY recommendation for LEGN on May 31, 2024 05:30AM ET. The previous analyst recommendation was Buy. LEGN was trading at $43.33 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York, NY on Thursday, June 6,...
First disclosure from Cohort D of the Phase 2 CARTITUDE-2 study investigating CARVYKTI ® in patients who had suboptimal response to frontline ASCT in an oral presentation at ASCO & EHA An oral presentation at ASCO of data from the Phase 3 CARTITUDE-4 study evaluating CARVYKTI...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...
2024-05-23 11:59:46 ET More on Legend Biotech Legend Biotech's Carvykti Faces Stiff Challenges Despite Advances Legend Biotech Corporation 2024 Q1 - Results - Earnings Call Presentation Legend Biotech Corporation (LEGN) Q1 2024 Earnings Call Transcript Legend...
2024-05-23 10:15:06 ET Deutsche Bank analyst issues BUY recommendation for LEGN on May 23, 2024 08:36AM ET. LEGN was trading at $40.845 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 7 - Buy recommendati...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 37.1% to $0.108 on volume of 436,246,446 shares Ascent Solar Technologies Inc (ASTI) rose 114.8% to $0.282249 on volume of 221,176,942 shares OneMedNet Corp (ONMD) rose 134.7% to $1.15 o...
2024-05-14 08:45:00 ET Summary Legend Biotech Corporation reported lower-than-expected Q1 earnings, reflecting struggles in Carvykti’s revenue generation despite strong market potential. Carvykti, despite superior indications compared to competitors, is hindered by high tox...
News, Short Squeeze, Breakout and More Instantly...
Legend Biotech Corporation Company Name:
LEGN Stock Symbol:
NASDAQ Market:
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...
VANCOUVER – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases in younger age groups than before. While researchers continue to search for a reason why this is happening, s...
2024-06-17 07:00:07 ET Asthika Goonewardene from Truist Financial issued a price target of $88.00 for LEGN on 2024-06-17 06:19:00. The adjusted price target was set to $88.00. At the time of the announcement, LEGN was trading at $42.45. The overall price target consensus...